Derbend Asset Management’s iShares Biotechnology ETF IBB Stock Holding History

Derbend Asset Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$1.45M	Buy	10,586 +3,409	+47%	+$466K	0.72%	28
2023 Q4	$975K	Buy	7,177 +1,269	+21%	+$155K	0.57%	35
2023 Q3	$723K	Buy	+5,908	New	+$751K	0.49%	39
2022 Q2	–	Sell	-1,811	Closed	-$276K	–	78
2022 Q1	$276K	Hold	1,811	–	–	0.27%	72
2021 Q4	$276K	Hold	1,811	–	–	0.27%	71
2021 Q3	$293K	Sell	1,811 -89	-5%	-$15K	0.28%	72
2021 Q2	$311K	Buy	+1,900	New	+$293K	0.29%	71

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Derbend Asset Management's IBB Position: Q1 2024 in Review

Derbend Asset Management increased its iShares Biotechnology ETF (IBB) stake by 47% in Q1 2024, buying an estimated $466K and bringing the position to 10,586 shares worth $1.45M. The position accounts for 0.72% of the portfolio, ranked #28.

Derbend Asset Management first reported a position in IBB in Q2 2021 and has held it in 7 quarters since. 899 funds tracked by Wall St. Rank hold IBB as of Q1 2024.

Derbend Asset Management held 10,586 shares of iShares Biotechnology ETF worth $1.45M as of Q1 2024.
Derbend Asset Management bought 3,409 iShares Biotechnology ETF shares in Q1 2024, an estimated $466K.
iShares Biotechnology ETF made up 0.72% of Derbend Asset Management's portfolio in Q1 2024, its #28 holding.
Derbend Asset Management first reported a position in iShares Biotechnology ETF in Q2 2021 and has held it in 7 quarters since.
899 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2024.

Based on Derbend Asset Management's 13F filing for Q1 2024, filed 30 Apr 2024.